Table 1 Comparison of included and excluded participants
Characteristics | Included | Excluded | P value | Excluded A1c 5.7-6.9 % | P value |
|---|---|---|---|---|---|
Number of Participants | 178 | 178 | 105 | ||
Continuous, Mean (SD) | |||||
Age, yrs | 59.1 (6.1) | 60.1 (7.7) | 62.1 (7.5) | ||
BMI, kg/m2 | 32.0 (2.7) | 31.1 (3.5) | 30.7 (3.4) | 0.002 | |
A1c, % | 6.1 (0.2) | 5.8 (0.5) | 6.2 (0.3) | ||
25(OH)D, ng/ml | 14.3 (5.1) | 15.2 (5.5) | 16.1 (5.7) | ||
eGFR, mL/min | 85.7 (16.1) | 87.1 (15.7) | 83.4 (14.1) | ||
Cholesterol, mg/dl | 182.2 (32.1) | 173.3 (32.9) | 175.8 (35.4) | ||
LDL, mg/dl | 111.9 (27.0) | 97.3 (31.2) | 101.6 (34.0) | ||
HDL, mg/dl | 44.6 (10.1) | 51.3 (13.9) | 0.001 | 49.7 (11.8) | 0.001 |
TG, mg/dl | 132.8 (59.4) | 124.8 (58.7) | 122.1 (58.4) | ||
AST, U/L | 27.0 (10.3) | 31.4 (15.6) | 27.0 (11.1) | ||
ALT, U/L | 45.8 (14.1) | 50.8 (20.7) | 47.5 (17.6) | ||
Charlson Index | 2.20 (1.17) | 2.85 (1.60) | 0.001 | 3.11 (1.66) | 0.001 |
Categorical, N (%) | |||||
HTN | 121 (68.0) | 117 (65.7) | 68 (64.8) | ||
Hyperlipidemia | 97 (54.5) | 84 (47.2) | 55 (52.4) | ||
DJD | 58 (32.6) | 68 (38.2) | 45 (42.9) | ||
CVD | 29 (16.3) | 31 (17.4) | 23 (21.9) | ||
Cancer | 23 (12.9) | 34 (19.1) | 24 (22.9) | ||
Psychiatric disorders | 129 (72.5) | 118 (66.3) | 59 (56.2) | ||
Anti-HTN medications | 108 (60.1) | 103 (57.9) | 61 (58.1) | ||
Thiazide diuretic use | 53 (29.8) | 37 (20.8) | 19 (18.1) | ||
Statins | 69 (38.8) | 61 (34.3) | 42 (40.0) | ||
Vit D supplements | 30 (17.4) | 48 (27.0) | 25 (23.8) | ||